Medical service portfolio
Specialty programs built to be delivered, not just described
Each program in the GHI portfolio combines a product or protocol with the clinical training, operational guidance and distribution support required to run it inside a real health system.
01 — Service area
Biologics
Personalized treatments developed to target the underlying causes of conditions such as autoimmune disorders and impaired wound healing.
Our biologics capability is built around personalized treatment design: therapies developed to address the underlying causes of a condition rather than its surface presentation, with a focus on autoimmune disorders and impaired wound healing. Each program is delivered alongside clinical training and implementation support, so partner facilities can adopt it within their existing care pathways.
02 — Service area
Diabetes
Programs addressing insulin resistance as part of long-term chronic disease management.
Insulin resistance sits upstream of much of the chronic disease burden our partners manage. Our diabetes programs combine treatment protocols with clinician education and monitoring frameworks, so that facilities can deliver and document care consistently across sites.
Insulin Resistance Reversal Treatment™
An IV-infused medication formula designed to support cellular glucose absorption and tissue repair.
03 — Service area
Neurodegenerative Disease
Age-related conditions, including Alzheimer's and Parkinson's disease, drawing on two decades of development work.
GHI has spent more than twenty years developing treatments for age-related and chronic conditions. Our neurodegenerative disease work is delivered through specialist centers and supported by training programs for the clinical teams who administer it.
yFFP®
Young fresh frozen plasma containing proteins and antioxidants that are associated with tissue rejuvenation.
04 — Service area
Advanced Diagnostics
Sequencing, molecular testing and analytical chemistry that give clinicians a clearer picture before treatment begins.
Diagnostics underpin everything else in the portfolio. Our diagnostic services span genomic sequencing, molecular testing and mass spectrometry, and are designed to be deployed inside existing laboratory workflows rather than alongside them.
Gene sequencing
Sequencing services applied to cancer and neurodegenerative disease investigation.
PCR testing
Molecular testing for rapid diagnostics across infectious and clinical panels.
PROSTest®
A test used in prostate cancer screening programs.
Medication-metabolism analysis
Analysis of how a patient metabolizes medication, performed by mass spectrometry.
Operating principles
What partners can expect
Designed around the procedure
We start from the constraints of the room where a product will actually be used. Solutions are built to fit established clinical workflows rather than asking teams to work around them.
Support that answers
We work directly alongside surgeons, facilities and distributors. Responsive support and dependable supply are part of the product, not an afterthought once the order ships.
Built for demanding environments
Healthcare teams work under real pressure. Our products and processes are designed to reduce friction rather than add to it, and to keep access predictable.
Adoption
Every program ships with training and distribution support
We work with health ministries, private medical systems and NGOs to integrate products and protocols into existing services — including certification for the clinical teams delivering them.
Contact
Begin a conversation with GHI
Whether you represent a strategic partner, a ministry of health, an NGO or a distribution network, we will route your inquiry to the right team within the group.
info@GHInnovators.com